BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1564598)

  • 1. Restoring patency of long-term central venous access devices.
    Holcombe BJ; Forloines-Lynn S; Garmhausen LW
    J Intraven Nurs; 1992; 15(1):36-41. PubMed ID: 1564598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hydrochloric acid to restore patency in an occluded implantable port: a case report.
    Kupensky DT
    J Intraven Nurs; 1995; 18(4):198-201. PubMed ID: 7629640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurse's guide to understanding and treating thrombotic occlusion of central venous access devices.
    McKnight S
    Medsurg Nurs; 2004 Dec; 13(6):377-82. PubMed ID: 15714740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
    Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
    Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue plasminogen activator for central venous access device occlusion.
    Hooke C
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):174-8. PubMed ID: 10944865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 6 years use of sodium hydroxide solution to clear partially occluded central venous catheters.
    Bader SG; Balke P; Jonkers-Schuitema CF; Tas TA; Sauerwein HP
    Clin Nutr; 2007 Feb; 26(1):141-4. PubMed ID: 17097197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
    Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and management of central venous access devices in the home setting.
    Cole D
    J Intraven Nurs; 1999; 22(6):315-9. PubMed ID: 10865598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring patency to central venous access devices.
    Cummings-Winfield C; Mushani-Kanji T
    Clin J Oncol Nurs; 2008 Dec; 12(6):925-34. PubMed ID: 19064386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
    Haire WD; Deitcher SR; Mullane KM; Jaff MR; Firszt CM; Schulz GA; Schuerr DM; Schwartz LB; Mouginis TL; Barton RP
    Thromb Haemost; 2004 Sep; 92(3):575-82. PubMed ID: 15351854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of central venous access device occlusion. Implications for nursing practice.
    Bagnall-Reeb H
    J Intraven Nurs; 1998; 21(5 Suppl):S115-21. PubMed ID: 9814286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of management of CVAD occlusions.
    Peng C; Monagle P; Newall F
    Arch Dis Child; 2011 Sep; 96(9):885-7. PubMed ID: 21398316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study).
    Blaney M; Shen V; Kerner JA; Jacobs BR; Gray S; Armfield J; Semba CP;
    J Vasc Interv Radiol; 2006 Nov; 17(11 Pt 1):1745-51. PubMed ID: 17142704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does low-dose heparin maintain central venous access device patency?: a comparison of heparin versus saline during a period of heparin shortage.
    Jonker MA; Osterby KR; Vermeulen LC; Kleppin SM; Kudsk KA
    JPEN J Parenter Enteral Nutr; 2010; 34(4):444-9. PubMed ID: 20631392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permanent central venous access devices.
    Wesley JR
    Semin Pediatr Surg; 1992 Aug; 1(3):188-201. PubMed ID: 1345487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of end-stage central venous access in children referred for possible small bowel transplantation.
    Rodrigues AF; van Mourik ID; Sharif K; Barron DJ; de Giovanni JV; Bennett J; Bromley P; Protheroe S; John P; de Ville de Goyet J; Beath SV
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):427-33. PubMed ID: 16641582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
    Svoboda P; Barton RP; Barbarash OL; Butylin AA; Jacobs BR; Lata J; Haire WD; Jaff MR; Firszt CM; Mouginis TL; Schuerr DM; Schulz GA; Schwartz LB; El-Shahawy MA
    Crit Care Med; 2004 Oct; 32(10):1990-6. PubMed ID: 15483405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of the POP technique for restoring patency to occluded PIC catheters.
    Fetzer SJ; Manning GP
    Appl Nurs Res; 2004 Nov; 17(4):297-300. PubMed ID: 15573339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transhepatic central venous catheter for long-term access in paediatric patients.
    Mortell A; Said H; Doodnath R; Walsh K; Corbally M
    J Pediatr Surg; 2008 Feb; 43(2):344-7. PubMed ID: 18280287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin sheaths and central venous catheter occlusions: diagnosis and management.
    Santilli J
    Tech Vasc Interv Radiol; 2002 Jun; 5(2):89-94. PubMed ID: 12489047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.